{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:59:21Z","timestamp":1786996761922,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015391","name":"Myositis Association","doi-asserted-by":"publisher","award":["K23-AR073927"],"award-info":[{"award-number":["K23-AR073927"]}],"id":[{"id":"10.13039\/100015391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR-041203"],"award-info":[{"award-number":["AR-041203"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30-AR070254"],"award-info":[{"award-number":["P30-AR070254"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.semarthrit.2021.04.012","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T12:18:27Z","timestamp":1619612307000},"page":"728-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["The phenotype of myositis patients with anti-Ku autoantibodies"],"prefix":"10.1016","volume":"51","author":[{"given":"Maria","family":"Casal-Dominguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iago","family":"Pinal-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assia","family":"Derfoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlan","family":"Michelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemima","family":"Albayda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tiniakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonye K.","family":"Danoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Christoper-Stine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie J.","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2021.04.012_bib0001","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13317-014-0060-4","article-title":"Myositis autoantibodies and clinical phenotypes","volume":"5","author":"Ghirardello","year":"2014","journal-title":"Auto Immun. Highlights"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0003","doi-asserted-by":"crossref","first-page":"e1768","DOI":"10.1212\/WNL.0000000000008443","article-title":"More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies","volume":"93","author":"Pinal-Fernandez","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0004","doi-asserted-by":"crossref","first-page":"e2068","DOI":"10.1212\/WNL.0000000000005638","article-title":"Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies","volume":"90","author":"De Lorenzo","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0005","doi-asserted-by":"crossref","first-page":"e1416","DOI":"10.1212\/WNL.0000000000007188","article-title":"Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies","volume":"92","author":"Casal-Dominguez","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0006","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.dnarep.2004.03.015","article-title":"The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination","volume":"3","author":"Lieber","year":"2004","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0007","first-page":"257","article-title":"Ku antigen: a versatile DNA binding protein with multiple cellular functions","author":"Schild-Poulter","year":"2004","journal-title":"Dyn. Genet. Res. Signpost"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0008","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0961203308089442","article-title":"Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases","volume":"17","author":"Cavazzana","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0009","first-page":"563","article-title":"Clinical and serological associations of anti-Ku antibody","volume":"26","author":"Cooley","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0010","first-page":"1393","article-title":"Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients","volume":"29","author":"Franceschini","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0011","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.4049\/jimmunol.136.5.1648","article-title":"Identification of Ki (Ku, p70\/p80) autoantigens and analysis of anti-Ki autoantibody reactivity","volume":"136","author":"Francoeur","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0012","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","article-title":"Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies","volume":"40","author":"Hausmanowa-Petrusewicz","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0013","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1084\/jem.161.1.18","article-title":"Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera","volume":"161","author":"Reeves","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0014","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/ard.2007.073981","article-title":"Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study","volume":"67","author":"Rozman","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/rheumatology\/kem338","article-title":"Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases","volume":"47","author":"Schild-Poulter","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0016","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/1529-0131(200110)44:10<2367::AID-ART400>3.0.CO;2-I","article-title":"Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus","volume":"44","author":"Wang","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0017","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/1529-0131(200003)43:3<689::AID-ANR27>3.0.CO;2-U","article-title":"Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases","volume":"43","author":"Yamamoto","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0018","first-page":"366","article-title":"Antibodies against Ku protein in sera from patients with autoimmune diseases","volume":"76","author":"Yaneva","year":"1989","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0019","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/annrheumdis-2018-214439","article-title":"Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes","volume":"78","author":"Spielmann","year":"2019","journal-title":"Ann. Rheum Dis."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.autrev.2009.03.005","article-title":"Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies","volume":"9","author":"Ronnelid","year":"2009","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0021","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/ar3550","article-title":"International cohort study of 73 anti-Ku-positive patients: association of p70\/p80 anti-Ku antibodies with joint\/bone features and differentiation of disease populations by using principal-components analysis","volume":"14","author":"Lakota","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0022","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0961203316640918","article-title":"Clinical and serological associations of autoantibodies to the Ku70\/Ku80 heterodimer determined by a novel chemiluminescent immunoassay","volume":"25","author":"Mahler","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0023","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.23899","article-title":"Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies","volume":"58","author":"O'Hanlon","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0024","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","article-title":"Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy","volume":"55","author":"Selva-O'Callaghan","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000000642","article-title":"Evaluation and construction of diagnostic criteria for inclusion body myositis","volume":"83","author":"Lloyd","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0026","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0027","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0028","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0029","first-page":"S118","volume":"63 Suppl 11","author":"Rider","year":"2011"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0031","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0032","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/annrheumdis-2018-214690","article-title":"Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies","volume":"78","author":"Espinosa-Ortega","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0033","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2018.10.004","article-title":"Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays","volume":"18","author":"Damoiseaux","year":"2019","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0034","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.autrev.2009.02.012","article-title":"Commercial blot assays in the diagnosis of systemic rheumatic diseases","volume":"8","author":"Ghirardello","year":"2009","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0035","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.41088","article-title":"Myositis Autoantibodies: a Comparison of Results From the Oklahoma Medical Research Foundation Myositis Panel to the Euroimmun Research Line Blot","volume":"72","author":"Mecoli","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.semarthrit.2021.04.012_bib0036","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s10067-020-04973-0","article-title":"Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies","volume":"39","author":"Hamaguchi","year":"2020","journal-title":"Clin Rheumatol."}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221000676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221000676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:17:34Z","timestamp":1778714254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221000676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0049017221000676"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.012","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The phenotype of myositis patients with anti-Ku autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}